Abstract:Recent developments in immunosuppressive therapy have reduced the loss of allografts from acute rejection, with a significant improvement in the one-year allograft survival. However, the introduction of more potent and selective new drug, had no effect on the development of chronic allograft dysfunction and the long-term outcome remains unchanged. Several and repeated different types of allograft insults such as delayed graft function, rejection episodes, drug nephrotoxicity, hypertension, dislipidemia determi… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.